Was Mansoor

Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study

Ángela Lamarca, Lynne McCallum, Christina Nuttall et al. · Expert Review of Gastroenterology & Hepatology · 2018 · 51 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

Elizabeth Smyth, Georgios Vlachogiannis, Somaieh Hedayat et al. · Gut · 2020 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours

Vanessa Clay, George Papaxoinis, Benjamin M. Sanderson et al. · Clinical & Translational Oncology · 2016 · 42 citations

Medicine, Oncology, Pathology +16

Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study

Josep Tabernero, Eric Van Cutsem, Yung‐Jue Bang et al. · Annals of Oncology · 2019 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma

Elizabeth Smyth, Samuel Rowley, Fay Cafferty et al. · JAMA Oncology · 2019 · 20 citations · Full text

Medicine, Oncology, Surgery +13